Morphologic characteristics of erythroleukemia (Acute Myeloid Leukemia; FAB‐M6): A CALGB study

FR Davey, Clara D. Bloomfield(North Shore University Hospital), Charles A. Schiffer(Veterans Health Administration), Doris H. Wurster‐Hill(Dartmouth College), James D. Griffin(Harvard University), Maria R. Baer(University of Maryland, Baltimore), Robert J. Mayer(Applied Natural Sciences), Virginia L. Brunetto(Roswell Park Comprehensive Cancer Center), Edward D. Ball(Sheba Medical Center), Douglas A. Nelson(Womack Army Medical Center), Neethu Abraham, Jane MacCallum(University of Pittsburgh)
American Journal of Hematology
May 1, 1995
10.1002/ajh.2830490106
Cited by 54

Related Papers

Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
|Blood|2009|4.4k
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
|Blood|2009|3.4k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
|Journal of Clinical Oncology|2003|2.7k